Cas:5308-28-1 1-Isobutylpiperazine manufacturer & supplier

We serve Chemical Name:1-Isobutylpiperazine CAS:5308-28-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Isobutylpiperazine

Chemical Name:1-Isobutylpiperazine
CAS.NO:5308-28-1
Synonyms:1-(2-methylpropyl)piperazine;MFCD00190596
Molecular Formula:C8H18N2
Molecular Weight:142.24200
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:65ºC (10 mmHg)
Density:0.864 g/cm3
Index of Refraction:1.446
PSA:15.27000
Exact Mass:142.14700
LogP:0.81430

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(2-methylpropyl)piperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00190596 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00190596 Use and application,MFCD00190596 technical grade,usp/ep/jp grade.


Related News: Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. (R)-N-(4-(dimethylamino)-2-butynyl)-5-methyl-2-pyrrolidone sesquioxalate salt manufacturers AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023. 2-[[4-[(2R)-2-[(tert-Butoxycarbonyl)[(2R)-2-[[tert-butyl(dimethyl)silyl]oxy]-2-(3-chlorophenyl)ethyl]-amino]propyl]phenyl]sulfonyl]-5-fluorobenzoic acid suppliers Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. Chaperonin GroEL (Listeria monocytogenes strain LO28 gene groEL) vendor & factory providing support for flexible, cross-sector training programmes to encourage more movement and collaboration between academia, industry and the charity sector,Flexibility in a CDMO is the key to ensure speed of tech-transfer which is a true litmus test for CDMOs which can help a company chose between competing analytical strategies, manufacturing technology and knowledge for improving productivity.